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Summary 
Data on husbandry practices, performance, disease and drug use were collected 
during a cross-sectional survey of 89 poultry meat farms in England and Wales to 
provide information on possible risk factors for the occurrence of fluoroquinolone 
(FQ) resistant bacteria. Faeces samples were used to classify farms as ‘affected’ or 
‘not affected’ by FQ-resistant E. coli or Campylobacter spp. Risk factor analysis 
identified the use of FQ on the farms as having by far the strongest association, 
among the factors considered, with the occurrence of FQ-resistant bacteria. 
Resistant E. coli and/or Campylobacter spp. were found on 86% of the farms with a 
history of FQ use. However, a substantial proportion of farms with no history of FQ 
use also yielded FQ-resistant organisms, suggesting that resistant bacteria may 
transfer between farms. Further analysis suggested that for Campylobacter spp., on-
farm hygiene, cleaning and disinfection between batches of birds and wildlife control 
were of most significance. By contrast, for E. coli biosecurity from external 
contamination was of particular importance, although the modelling indicated that 
other factors were likely to be involved. Detailed studies on a small number of sites 
showed that FQ-resistant E. coli can survive routine cleaning and disinfection. It 
appears difficult to avoid the occurrence of resistant bacteria when FQ are used on a 
farm, but the present findings provide evidence to support recommendations to 
reduce the substantial risk of the incidental acquisition of such resistance by farms 
where FQ are not used. 
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Introduction 
Antimicrobial resistance amongst farm strains of enteric zoonotic bacteria, such as 
E. coli and thermotolerant Campylobacter spp., is of concern, particularly in view of 
the risk it presents for human disease, persistent enteric colonisation and 
(theoretically) transmission of resistance to other enteric bacteria (ECDC/EFSA/EMA, 
2015). E. coli is a ubiquitous enteric commensal in both human and veterinary 
species, with a small subset of strains that present veterinary, human and cross-
species disease hazards due to particular colonisation factors and/or toxins (Hartl & 
Dykhuizen, 1984). Campylobacter spp. are the most commonly identified human 
gastrointestinal pathogens reported in the European Union, confirmed in over 
220000 cases in 2011 (EFSA/ECDC, 2013). 
 
In recent community-wide data from the European Union resistance to the 
fluoroquinolone (FQ) antibiotic ciprofloxacin was found to be high (44% to 78% of 
isolates overall, depending on source and subspecies) among Campylobacter jejuni 
and Campylobacter coli isolates from human (mostly clinical) and broiler 
(monitoring) sources (EFSA/ECDC, 2014). A survey of 145 Campylobacter spp. 
isolates from human, milk, poultry and cattle sources in Italy similarly found 63% 
exhibiting ciprofloxacin resistance but comparatively little resistance to other tested 
antimicrobials, with the exception of tetracycline (Di Giannatale et al., 2014). A 
survey in Chile revealed a similarly high frequency of ciprofloxacin resistance among 
poultry and human Campylobacter spp. isolates (around 60%), whilst only 18% of 
isolates from cattle were resistant (Gonzalez-Hein, Cordero, Garcia & Figueroa, 
2013). For Campylobacter, all these data are in the context of subtyping studies 
indicating that 50% to 80% of human cases may be linked, directly or indirectly, to 
the chicken reservoir, and of FQ being one of the principal drugs of choice for 
treating human campylobacteriosis (EFSA, 2010; Agunos et al., 2013).  
 
Aggregated European Community data for E. coli isolates from broilers showed, 
similarly to Campylobacter spp., that over 50% of isolates were resistant to 
ciprofloxacin (EFSA/ECDC, 2014). A sampling study provided evidence for the 
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dissemination of individual and multiple antimicrobial resistances in E. coli from 
turkeys and broilers to their human handlers (van den Bogaard, London, Driessen & 
Stobberingh, 2001). Furthermore, FQ-resistant isolates from human bacteraemias 
and faeces were found to be more closely related to chicken isolates than to FQ-
susceptible human isolates in another study (Johnson et al., 2006). 
 
Data from Australia, where FQ are restricted in the medical field and not used in 
food animals, has shown that FQ resistance among human Campylobacter spp. 
isolates has been slow to emerge, compared with other territories. Similarly, there is 
a low frequency of FQ resistance among Australian human disease-causing E. coli 
isolates (Cheng et al., 2012).  
 
Attempts at restricting antimicrobial resistance on farms have included various 
guidelines for the prudent use of veterinary antimicrobials (RUMA, 2005; OIE, 2014; 
AAAP-AVMA, 2015). However, these have been based in large part upon expert 
opinion, as published analyses of risk factors for the development of such resistances 
are lacking. 
 
The present report details a risk factor analysis performed following a survey for the 
prevalence of FQ resistance among E. coli and Campylobacter spp. on poultry units in 
the UK. Questionnaire data was used in conjunction with the prevalence results to 
analyse FQ resistance with respect to a range of environmental and management 
factors. The overall prevalence results for poultry and pigs and the analysis for risk 
factors on pig farms have been reported elsewhere (N.M. Taylor et al., 2008; N. 
Taylor, Clifton-Hadley, Wales, Ridley & Davies, 2009) 
 
Materials and Methods 
Data collection 
Two programmes of sampling were undertaken. For the first, 89 poultry meat farms 
were included in a cross-sectional survey of FQ-resistant (FQr) E. coli and 
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Campylobacter spp., the details of which are described elsewhere  (N.M. Taylor et 
al., 2008). Briefly, 68 broiler and 21 turkey farms were each sampled once between 
June 2001 and June 2003, with 64 separate fresh floor droppings being collected 
from random locations in up to four houses and combined into eight pools of eight 
samples each. The sample size and sampling strategy were designed to give a 95% 
probability of detecting resistant isolates if at least 5% of animals in the sampled 
houses were shedding resistant bacteria and laboratory detection was 90% sensitive. 
 
Sampling on poultry company premises was performed either by company-
appointed poultry veterinarians or by poultry company staff under the supervision of 
the company veterinarian. Independent poultry producers (20 farms) carried out the 
sampling themselves. To provide information on possible factors associated with 
farms’ FQ resistance status, data about husbandry practices, performance, disease 
and drug use, including use of non-FQ antibiotics, were collected using detailed 
questionnaires filled in by the farm manager with the veterinarian doing the 
sampling, or by independent producers themselves. Data on antibiotic use was 
acquired, in the large majority of cases and by all large units, by reference to detailed 
treatment records in the farm diaries. These records are audited regularly for the 
purposes of quality assurance and food chain protection. 
 
The second (follow-up) programme investigated the potential for dissemination and 
persistence of FQr organisms by carrying out farm-level sampling at representative 
stages of breeding and production networks in two integrated companies.  Faeces 
sampling and data collection were carried out by the farm manager, according to the 
protocols used for the first study, in five breeding flocks on repopulation, nine 
breeding flocks in mid to late lay and 28 broiler flocks in mid to late rear. On a 
selected proportion of sites where FQr organisms were found, intensive sampling 
was performed by staff from the research team to investigate the distribution of 
resistant E. coli on premises and to study their survival after cleaning and disinfection 
(C&D). Samples taken on VLA sampling visits included faeces, water, dust and surface 
swabs from building structures and equipment, as well as swabs from deep cracks in 
walls and floors. 
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Bacteriology 
Bacteriological analysis of faeces pools was performed using liquid media (buffered 
peptone water [BPW] and Exeter’s Enrichment Broth for E. coli and Campylobacter 
spp., respectively) and selective solid media with added 1.0 mg/l ciprofloxacin 
(Chromagar ECC for E. coli; sheep blood agar plus Skirrow’s antibiotic supplement 
and cefoperazone [BASAC] for Campylobacter spp.) as previously described (N.M. 
Taylor et al., 2008). Farms were thus classified as ‘affected’ or ‘not affected’ with 
respect to FQr E. coli or Campylobacter spp., using a selective concentration of 
ciprofloxacin that is similar both to contemporaneous tentative breakpoints (Luber, 
Bartelt, Genschow, Wagner & Hahn, 2003; USDA, 2005), and  the current European 
clinical breakpoint (EUCAST, 2014). Putative E. coli colonies were confirmed using 
standard biochemical tests, campylobacters were identified to species level by 
standard microbiological procedures, and minimum inhibitory concentration (MIC) 
values of ciprofloxacin were determined as described elsewhere (N.M. Taylor et al., 
2008). Non-faeces samples from intensive sampling visits in the second sampling 
programme were incubated in approximately 10-fold volumes of BPW (225 ml for 
surface swabs) and incubated as for faeces samples, before plating onto Chromagar 
ECC. Serotyping, toxin testing and antibiograms (not including FQ) by the disc 
diffusion method were carried out using standard protocols. 
 
Statistical analyses 
Statistical analyses were conducted using data from the first sampling programme 
only. Associations between FQ use and farm types, and between FQ use and the 
presence of FQr target organisms, were investigated using Chi-squared and Fisher’s 
exact tests. Calculations of relative risks associated with reported FQ use, with 95% 
confidence intervals, were carried out using EpiInfo version 6 (Centers for Disease 
Control and Prevention  U.S.A. & World Health Organisation, Geneva, Switzerland). 
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Correlation and cluster analyses and logistic regression modelling were carried out 
using SAS version 8 (SAS, 1999). The approach taken was exactly the same as that 
used in analysing data from pig farms (N. Taylor et al., 2009). Briefly, the 
questionnaire data were first placed in blocks according to subject matter (e.g. farm 
characteristics, farm hygiene, biosecurity, drug usage including other antibiotics) and 
then the variables within each block were screened using Ward’s minimum variance 
cluster analysis to identify groups of related variables (Ward, 1963; Everitt, 1980). 
From each group thus identified, a representative variable was selected (using 
epidemiological significance plus data variability and completeness as criteria) as a 
candidate explanatory variable in logistic regression modelling within each block of 
variables, with the presence on a farm of FQr E. coli or FQr Campylobacter spp. as 
outcome variables. 
By this method a number of candidate explanatory variables were identified from 
each block. These variables were re-analysed by Ward’s minimum variance cluster 
analysis regardless of their block of origin. Some variables closely correlated with 
other, more epidemiologically pertinent, ones were removed from the analysis at 
this stage. The retained candidate variables from all blocks were then tried together 
in logistic regression modelling, with results given as a list of risk factors for 
occurrence of FQ resistance in each bacterial species, quantified in terms of adjusted 
odds ratios. 
An r2 value, that estimates the proportion of variation in the data explained by the 
model, was calculated for each model, according to the method of Nagelkerke (1991) 
as recommended by Collett (2003). 
Results 
Bacteriological findings 
First sampling programme. Findings have been reported in detail by Taylor et al. 
(2008). FQr E. coli were isolated from 53 of the 89 farms. FQr Campylobacter spp. 
were isolated from 20 of the 89 farms. Of tested isolates obtained from the 
1.0 mg/ml ciprofloxacin screening plates used, 79% of E. coli and 70% of 
Campylobacter spp. isolates had MIC values for ciprofloxacin of 16 mg/l or greater. 
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Second sampling programme. Of the five breeding flocks tested on repopulation in 
this follow-up investigation, none reported use of FQ during the previous six months 
or yielded FQr E. coli or Campylobacter spp.. Among the nine breeding flocks tested 
in mid- to late lay, FQr E. coli was isolated from two, but FQr Campylobacter spp. was 
not isolated. One of these nine flocks reported FQ use (in one of two houses) in the 
previous six months. Of the 28 broiler farms tested in mid-late rear, 25 yielded FQr 
E. coli. No FQr Campylobacter spp. was isolated. FQ had been administered during 
the previous six months on only one of these farms, in non-sampled parts of the 
farm, and all samples from this farm yielded FQr E. coli. 
 
Further intensive sampling visits, for FQr E. coli, were carried out at one of the mid-
lay breeding flocks, a linked company hatchery and after C&D on two of the 
commercial broiler sites. From the breeding flock, FQr E. coli was isolated from 16 of 
100 environmental samples. It was most frequently found in fresh faeces and litter 
(rather than nest boxes), but also found in guttering and on the concrete apron 
outside the house. At the hatchery, FQr E. coli was found in six of the 100 samples 
taken from meconium and egg/chick waste, as well as on cleaned and disinfected 
surfaces. On both post-C&D broiler farms, FQr E. coli was found in cracks and 
crevices, pooled wash water, ante-rooms which had been less well disinfected and 
fresh droppings from wild birds collected from the house exterior. 
 
Seventy two E. coli strains from the second sampling programme were examined for 
MIC and serotype. Isolates were from breeder units in mid-lay, broiler units and the 
hatchery. Ciprofloxacin MIC values were ≥ 8 mg/l, with a modal value of 16 mg/l.  
Eight serovars were identified, and 12 isolates proved untypable. There was no 
overlap between identified serovars isolated from breeder versus broiler  flocks. 
Thus, there was no evident relationship between breeder and broiler isolates. One of 
the three serovars isolated from the hatchery was associated with the breeder 
flocks, and another with the broiler flocks. 
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From one company, E. coli O101:K+ (verocytotoxin-negative, MIC 32 mg/l) was 
isolated in five broiler flocks in mid-late rear on one farm.. The same serovar was 
also found on two other farms from the same company, in two sequential flocks on 
each farm. FQr E. coli O9:K+ was isolated from two of the breeding flocks (MIC 
8 mg/l) and from a waste skip at the hatchery (MIC 16 mg/l). However, this serovar 
was not amongst the isolates tested from broiler units within the company. 
 
The 72 serotyped E. coli isolates were also tested for resistance to antibiotics. 
Several patterns were found, with resistance to ampicillin (86% isolates), 
sulphamethoxazole/trimethoprim (65% isolates), tetracycline (67% isolates) and 
streptomycin (43% isolates) being the most frequently encountered, in addition to 
quinolone/FQ resistance. 
 
Use of antibiotics and risk of fluoroquinolone resistance on the surveyed farms 
The questionnaire response options in relation to use of FQ on farms were: ‘within 
12 months’, ‘between one and two years ago’, ‘over two years ago’ and ‘never’. The 
responses are summarised in Table 1. Use of FQ was reported on 22 of 88 (25%) 
poultry farms in the survey, with one no-response. FQ use was significantly (Chi2 
p < 0.0001) more common on turkey farms (14/21) than on broiler farms (8/67). 
Among the broiler farms, FQ use was significantly (Chi2 p < 0.0001) more common by 
independent producers (7/18) than by large poultry company farms (1/49). Amongst 
turkey farms the most recent use had been within a year on nine of the 14 farms 
that reported use. On broiler farms, only two of the eight reporting use of FQ had 
done so within the last year (Table 1). On all except one farm, FQ were administered 
through water medication. In turkeys, the most common problem treated with FQ 
was reported as being ‘E. coli septicaemia’. Amongst broilers, the most common 
problems reportedly associated with FQ use were ‘yolk sac infections’ or ‘stunted 
chicks’. Use, in the previous 12 months, of non-FQ antibiotics other than amoxicillin 
(41% of farms), lincospectin (22% of farms) and tetracycline (10% of farms) was 
uncommon. Just under one fifth of farms reported routine use of in-feed antibiotic. 
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FQr E. coli or FQr Campylobacter spp. were detected on 19 (86%) of the 22 farms 
that had used FQ and 40 (61%) of the 66 farms that reported never using FQ. The 
prevalence of farms positive for FQr E. coli or FQr Campylobacter spp. was not 
significantly different between farms with most recent use of FQ over one year ago, 
compared with those using FQ within the last year. Therefore, farms where any FQ 
use was reported were grouped together for comparison with those farms reporting 
that they had never used FQ in further analyses. Table 2 shows the relative risks 
(with 95% confidence intervals) for the occurrence of FQ resistance on poultry farms, 
associated with the use of FQ. 
 
Overall within-farm prevalence values for FQr Campylobacter spp. and E. coli were 
around 5% and 20% of faecal pools, respectively. On some premises, resistant 
Campylobacter were shed by birds in only one or two houses, but there were others 
where shedding birds were present across the farm. Birds shedding FQr E. coli 
tended to be distributed throughout the houses on affected farms. 
 
Modelling of risk factors for the occurrence of FQ-resistance 
Correlation and clustering analysis revealed that farm type (turkey or broiler; 
independent grower or large company) was strongly correlated with several of the 
variables. Specifically: 
 Turkey farms were strongly positively correlated with the use of FQ, cleaning 
and disinfecting header tanks, seeing more than five rats at depopulation, the 
use of plastic drinkers for chicks, and the use of growth promoters and 
tetracyclines. 
 Turkey farms were strongly negatively correlated with single-handed 
operation, enclosure by a perimeter fence, the provision of wheel dips, wild 
bird access to poultry houses, the presence of dogs or cats, cleaning and 
disinfecting ante rooms, feed hoppers and areas outside houses, and the use of 
nipple drinkers and digestive enzymes. 
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 Independent farms were strongly positively correlated with the use of FQ, the 
presence of dogs or cats, slaughtering birds at an older age and cleaning and 
disinfecting ante rooms. 
 Independent farms were strongly negatively correlated with the provision of 
masks and wheel dips, seeing more than five rats at depopulation, cleaning and 
disinfecting header tanks, and the use of digestive enzymes and growth 
promoters. 
 
In addition, the correlation analysis indicated the following: 
 Single-handed farms tended not to have wheel dips. 
 Farms enclosed by a perimeter fence tended to provide wheel dips and have 
dogs or cats. 
 Farms enclosed by a perimeter fence tended not to have big houses, tended 
not to be turkey farms and, therefore, tended not to use growth promoters 
and tetracycline. 
 Larger farms tended to provide masks to staff. 
 Dusting of all detailed areas was positively correlated with wet cleaning of all 
detailed areas and removal of all wash water from the site. 
 C&D of ante rooms was strongly positively correlated with C&D of feed 
hoppers. 
 In this particular sample of poultry farms, the variable ‘provision of a mask’ was 
also positively correlated with provision of hat and gloves and provision of 
hand sanitiser and provision of a toilet. 
 
The turkey farm type was very strongly associated with the use of FQ. The turkey 
farm variable itself was not significant in the final models. This implies that the 
reason for the increased proportion of turkey farms with FQr E. coli or 
Campylobacter spp., compared with broiler farms, as reported previously (N.M. 
Taylor et al., 2008), is fully explained by other variables in the model, chiefly the use 
of FQ on the farms. 
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The results of the final regression modelling are presented in tables 3 and 4 showing 
the variables included as risk factors, estimates of coefficients with p-values, the 
estimated adjusted odds ratios with 90% and 95% confidence intervals and the r2 
value.  
 
Having fitted main effects, several interactions were identified as statistically 
significant but inclusion of these in the regression models always resulted in 
estimates for some odds ratios approaching infinity or zero. This was considered to 
be the result of small sample sizes, such that inclusion of too many effects, notably 
the interactions, produced models that were ‘over-fitted’, as described by Collett 
(2003). To avoid the possibility of over-fitting and implausible interpretations, 
models were finalised without interactions. 
 
Table 3 provides a summary of the factors included in the final fitted logistic 
regression model for the risk of occurrence of FQr E. coli. Significant factors 
increasing risk are: use of FQ in past, single-handed operation of the site, and the 
existence of a public footpath on the periphery of the site. The sole significant factor 
decreasing risk is enclosure of the site by a perimeter fence. The r2 value of the fitted 
model is fairly low, which indicates that other, unidentified, explanatory risk factors 
are likely to be involved. 
 
Table 4 provides a summary of the factors included in the final fitted logistic 
regression model for the risk of occurrence of FQr Campylobacter spp. Significant risk 
factors increasing risk are: the use of FQ in the past and wild birds having access to 
poultry houses. Significant factors decreasing risk are: more than the median (for all 
broiler or turkey farms in the sample, as appropriate) number of birds on site, the 
site operated by an independent grower, masks provided for staff, detailed areas 
dusted before wet cleaning, and feed hoppers cleaned and disinfected. 
 
The r2 value is over 50%, indicating that the model provides a good explanation of 
factors affecting the occurrence of FQ-resistant Campylobacter spp.. However, the 
model is fitted with quite a large number of variables (seven) in relation to the 
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dataset size (n = 84) and is in danger of being ‘over-fitted’. The result of this is the 
relatively wide confidence intervals for the adjusted odds ratios. Nevertheless, the 
fitted variables are statistically significant. The conclusion is that the factors in the 
model affect risk significantly, and perhaps greatly, but the data are not sufficient to 
allow the risk effect to be quantified very precisely. 
 
Discussion 
The bacteriological findings of the initial survey (N.M. Taylor et al., 2008) and the 
follow-up studies reported here have identified the frequent occurrence of  E. coli 
and Campylobacter spp. with FQ resistance on a substantial proportion of turkey and 
broiler commercial production facilities. FQr E. coli were also isolated on breeding 
flock premises. Moreover, the FQr E. coli and Campylobacter spp. typically exhibited 
clinically-significant elevations in MIC values (Becnel Boyd et al., 2009; EUCAST, 
2014) and the FQr E. coli often showed resistance to other classes of antimicrobial 
agents. The present findings for E. coli are similar, in terms of frequency of isolation 
on FQ resistance-selective media, MIC values observed, and common co-resistances 
with other classes of antimicrobial drugs, with the findings of Gosling et al. (2012). 
That study used UK-wide samples from turkey units taken for a European Union 
baseline survey. 
 
It was initially hypothesised that FQr organisms would be found on a small 
percentage of farms, principally those where FQ were used. However, in the first 
(structured) survey FQr organisms (mostly E. coli) were detected on a heavy majority 
(86%) of farms that had used FQ in the past, and also on over half (61%) of the farms 
that reported never using FQ. This finding is similar to that of a concurrent survey in 
pig production (N. Taylor et al., 2009). A history of FQ use was associated with an 
approximately doubled risk that FQr E. coli or Campylobacter spp. would be found on 
a farm, and with the highest odds ratios among all the factors considered in the 
logistic regression models for FQ resistance on farm.   
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The substantial prevalence of FQ resistance-affected farms that had never used FQ 
suggests that FQr organisms may commonly be imported onto farms, either with 
replacement birds in the case of E.coli, or from environmental sources in the case of 
Campylobacter spp.. The persistence of such strains correlates with experimental 
data suggesting little or no fitness cost associated with a moderate degree of FQ 
resistance in E. coli (Schrag, Perrot & Levin, 1997) and Campylobacter spp. (Q. Zhang, 
Lin & Pereira, 2003). This is consistent with the experience in countries where FQ are 
either prohibited or not specifically licensed in poultry farming (USA, Canada and 
Denmark), where FQ resistance among Campylobacter spp. isolates from poultry 
sources has not consistently declined following cessation of FQ use in the sector 
(Agunos et al., 2013; DANMAP, 2014). 
 
There are, inevitably, some reasons to be careful in interpreting the present analysis. 
The influence of co-resistance involving FQ resistance plus other antibiotics needs 
some consideration, despite no significant associations being found between FQ 
resistance on premises and recent use of a specific antibiotic class.  
 
In Campylobacter spp., resistance to FQ typically is mediated by mutation of a 
chromosomally-encoded topoisomerase, which is a mechanism specific to quinolone 
antibiotics (Qijing Zhang, Lin & Pereira, 2003; Gyles, 2008). This is augmented in 
some cases by overexpression of the chromosomally-encoded multi-drug efflux 
pump CmeB (Fàbrega, Sánchez-Céspedes, Soto & Vila, 2008). Therefore, clinical 
resistance to FQ is unlikely to occur consequent upon use of a different antibiotic 
class or by introduction on mobile genetic elements. However, as shown in the 
present study and elsewhere (Pérez-Boto, García-Peña, Abad-Moreno & Echeita, 
2013), FQ resistance in Campylobacter spp. from poultry farms is often accompanied 
by other antibiotic resistances in the same isolates. If FQ resistance is, for whatever 
reason,  more common amongst antibiotic-resistant strains than among susceptible 
strains, then co-selection by other antibiotics may maintain pre-existing FQr strains 
for a prolonged period, especially if , as appears to be the case, the fitness cost of FQ 
resistance among Campylobacter spp. is low (Luo et al., 2005). It is therefore 
important to note that, whereas FQ resistance clearly has the potential to persist in 
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the absence of FQ use by co-selection, it seems unlikely to be present in the first 
instance without either being introduced from elsewhere, or following selection by 
FQ use. 
 
For E. coli, the picture is perhaps more complicated. High-level FQ resistance is firmly 
associated with topoisomerase mutation(s) (Fàbrega et al., 2008; Gyles, 2008; Vanni 
et al., 2014), although intermediate resistance or enhancement of clinical resistance 
is possible by chromosomal efflux pump upregulation and/or plasmid-borne genes 
encoding target site protection (qnr), efflux (qepA) or FQ modification by an 
aminoglycoside acetyltransferase  (aac(6′)-Ib-cr) (Fàbrega et al., 2008; Yue et al., 
2008; Veldman et al., 2011). Therefore, intermediate FQ susceptibility may be 
introduced or maintained by horizontal transfer and/or co-selection by the use of 
other antibiotic classes. However, no non-FQ antibiotics are likely to select the 
spontaneous topoisomerase mutations fundamental to clinical resistance levels. 
 
Although the prevalence of FQ resistance among contemporaneous diagnostic avian 
samples of E. coli in the UK was low (around 2% to 6% depending on region and 
source), resistances to commonly-used antimicrobials were more prevalent, in the 
range 23% to 65% of isolates for ampicillin, amoxicillin, spectinomycin and 
trimethoprim/ sulphonamide (Anon., 2007), consistent with the resistance findings 
in the present study. This suggests that many FQ-resistant E. coli would also have 
had resistance to other therapeutic antibiotics. Like Campylobacter spp., this might 
facilitate co-selection of FQ resistance by other antibiotics but would not be 
expected to generate de novo the clinical degree of resistance seen in the present 
study. 
 
The second sampling programme and typing studies reinforce the finding of the 
initial survey that the presence of FQr E. coli on a farm may not necessarily be 
related to recent recorded use of FQ on the premises. The FQr E. coli isolated 
belonged to numerous serogroups and had a range of different antibiograms, 
indicating that they did not belong to a single clone. Furthermore, the FQr E. coli on 
the two farms tested after C&D were able to persist in the environment and were a 
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potential source of infection for a new flock. A pertinent allied observation from the 
initial survey is that, on farms where FQ had been used, there was no significant 
effect seen of the time elapsed since last use upon the risk of FQ resistance. It is  
interesting to note in this context that Ingram et al. (2013) isolated FQr E. coli 
harbouring multidrug-resistance plasmids from chicken carcasses in Australia (a 
territory where FQ are not licensed for poultry), thereby showing that 
topoisomerase-mutants may be present commonly in products from apparently FQ-
free systems. 
 
The second sampling study also provided observational evidence that, for E. coli at 
least, FQr strains potentially can transfer between broiler premises within integrated 
operations, presumably via personnel and fomites. There was no evidence of vertical 
transmission of FQr E. coli from breeder to broiler flocks, which may reflect the 
biosecurity barrier that can be achieved between these levels of production by 
hygienic hatchery management. 
 
The differences in risk factors identified for the two bacterial genera examined may 
reflect differences in the usual modes of transfer of these organisms between 
locations. Interested readers are directed to Taylor et al. (2009) for discussion of the 
merits and limitations of the statistical modelling approach of the present study. In 
addition to FQ use and single-handed operation, the two variables identified as 
significant risk factors for the occurrence of FQr E. coli were the existence of a 
perimeter fence (protective) and of a public footpath (increasing risk). Thus, in 
common with pig units, biosecurity appears to be of high importance for FQr E. coli. 
For poultry the physical integrity of the farm limits seems to be of primary 
significance, whereas for pigs the proximity of  other pig units and visitor biosecurity 
was found to be important (N. Taylor et al., 2009). 
 
These differences in the most significant biosecurity barriers for pigs versus poultry 
farms may to some extent reflect differences in the frequency of visitors and of feed 
and stock transporters, differences in the housing systems, in the typical farm sizes, 
and in the typical local environments. Whilst risk factor analysis may identify areas of 
 17
particular vulnerability or strength for particular enterprise types, examination of 
any particular unit would sensibly include a comprehensive overview of biosecurity 
issues, especially as the relatively low r2 value for the E. coli model indicates other 
significant unidentified risk factors that may not be common to all or most units. 
 
For Campylobacter spp., the risk factor model for the occurrence of FQ resistance 
indicates the importance of farm hygiene, perhaps reflecting the greater importance 
of shorter-range transmission between animals for this more environmentally labile 
pathogen when compared with E. coli. One protective factor of particular interest 
was provision of a mask. This factor was positively correlated with, and effectively a 
proxy variable for, other factors including the provision of hand sanitisers, a toilet, 
hats and gloves. The inclusion of this factor in the model can be taken as indication 
of the protective effect of better hygiene facilities in general. 
 
The significantly protective variables regarding dusting (of several difficult or 
inaccessible parts of poultry houses before wet cleaning) and C&D of feed hoppers 
are interpreted as indicators of generally superior farm cleaning. Campylobacters are 
frequently recovered from puddles and other wet locations on farms, but typically 
not from dry materials. The findings indicate the importance of attention to detail 
when cleaning between crops, presumably by preventing carry-over of infection, 
particularly of Campylobacter spp., between batches of stock. 
 
The introduction of Campylobacter spp. (including, potentially, FQr strains) to a 
poultry flock or premises is considered to be a more important issue than carry-over, 
and may occur following the repeated entrance of staff with contaminated clothing, 
hands or equipment (Newell et al., 2011). The risks of acquisition of Campylobacter 
spp. by flocks before slaughter are related to several factors including: season, on-
farm hygiene, other animal species on the farm, more than one poultry house per 
stockperson, thinning of slaughter-age flocks by catching crews and features of the 
farm environmental surroundings, as reviewed by Vidal et al., (2014). However, 
Refregier-Petton et al. (2001) reported a risk factor analysis for the presence of 
Campylobacter spp. in broilers at slaughter using a similar methodology to the 
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present one and found, amongst other things, that no specific stockperson hygiene 
practices were significant. Discrepancies noted in that report between claimed and 
observed hygiene practices may explain this finding, and its apparent lack of 
concordance with the present evidence. 
 
The transmission of FQr Campylobacter spp., and probably of Campylobacter spp. 
more generally, may also be associated with wildlife vectors. Remarkable 
suppression of seasonal peaks in flock Campylobacter spp. colonisation has been 
demonstrated, in the context of good general hygiene, following the use of mesh 
screens to exclude wildlife down to the level of flying insects from broiler houses 
(Bahrndorff, Rangstrup-Christensen, Nordentoft & Hald, 2013). The factor, ‘saw 
more than five rats at last depopulation’ was associated with an increased risk, but 
was not significant in the final model. Access to the poultry houses by wild birds was 
a significant factor for increasing risk in the final model, with a large odds ratio. It has 
been documented that wild birds carry Campylobacter spp., including FQr strains 
(Broman et al., 2002; Waldenstrom et al., 2005), although wild bird strains generally 
differ from poultry and human strains (Broman et al., 2004). Access by wild birds 
may be indicative of poorer biosecurity with respect to wildlife more generally. 
 
In conclusion, the present investigations have illustrated the strong association 
between any use of FQ on poultry farms and the presence of E. coli and/or 
Campylobacter spp. with clinically-relevant levels of resistance to FQ on the same 
premises. Furthermore, the introduction or maintenance of FQr organisms on farms 
appears significantly influenced by farm hygiene (Campylobacter spp.) and boundary 
biosecurity (E. coli), with evidence also being found of cross-transfer of FQr E. coli 
between premises linked in the production system. As has been discussed elsewhere 
(N.M. Taylor et al., 2008), both E. coli and Campylobacter spp. are zoonotic 
organisms for which FQ are therapeutic agents in humans. It appears, on the present 
evidence, to be difficult for farms that use FQ to avoid the development of FQ-
resistant E. coli and Campylobacter spp. on farm. However, for those farms that do 
not use FQ, an emphasis on excellence in biosecurity and on-farm hygiene is likely to 
prove protective. The benefits of such a strategy are likely to extend to control or 
 19
exclusion of some other infectious agents also. This is in line with guidelines 
produced by the UK ‘Responsible Use of Medicines in Agriculture Alliance’ (RUMA; 
http://www.ruma.org.uk), which stress that the use of antimicrobials should be seen 
as complementing good management, vaccination and site hygiene. 
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Table 1: Detection of fluoroquinolone (FQ)-resistant bacteria on poultry farms, compared with reported use of FQ 
Last use of FQ antibiotics Broiler farms Turkey farms All farms 
Number with FQ resistance 
E. coli Campylobacter 
In last year   2 9 11 10  (91%)   4  (36%) 
Over 1 year ago   6a 5b 11   9  (82%)   4  (36%) 
Never used 59 7 66 33  (50%) 11  (17%) 
a: 2 of 6 reported most recent use over 2 years ago b: 1 of 5 reported most recent use over 2 years ago   
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Table 2: Relative risks (with 95% confidence intervals) for the occurrence of fluoroquinolone (FQ) resistance on poultry farms, associated with the reported use of FQ 
 Proportion of farms with FQ resistance 
 E. coli Campylobacter 
FQ used (n = 22) 0.86 0.36 
FQ never used (n = 66) 0.50 0.17 
Relative Risk (95% C.I.) 1.73 (1.29 – 2.32) 2.18 (1.01 – 4.72) 
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Table 3: Estimated adjusted odds ratios, with confidence intervals (C.I.s), of variables included as risk factors in the final logistic regression model for the occurrence of fluoroquinolone (FQ)-resistant E. coli on poultry farms 
Risk Factor co-efficient p-value* 
Lower Limit C.I.s Odds ratio point estimate 
Upper Limit C.I.s 
95% 90% 90% 95% 
Constant - 0.204 0.6294      
Use of FQ in the past 2.049 0.0016 1.85 2.31 7.76 26.04 32.48 
Site operated single-handedly 0.948 0.073 0.89 1.06 2.58 6.30 7.46 
Site enclosed by a perimeter fence - 1.302 0.014 0.09 0.11 0.27 0.67 0.79 
Site has public footpath on the perimeter 1.407 0.019 1.17 1.43 4.09 11.67 14.20 
n = 83; maximum re-scaled r2 = 29.9% *p-value is based on likelihood ratio test.   
 27
Table 4: Estimated adjusted odds ratios of variables, with confidence intervals (C.I.s), of variables included as risk factors in the final logistic regression model for the occurrence of fluoroquinolone (FQ)-resistant Campylobacter spp. on poultry farms 
Risk Factor co-efficient p-value* 
Lower limit C.I.s Odds ratio point estimate 
Upper limit C.I.s 
95% 90% 90% 95% 
constant 1.476 0.2387      
Use of FQ at any time in past 2.685 0.0052 1.64 2.32 14.65 92.59 130.59 
No. of birds on site higher than median - 2.182 0.0097 0.02 0.024 0.11 0.54 0.73 
Site owned by an independent grower - 3.156 0.0031 0.00 0.005 0.04 0.36 0.54 
Masks provided for staff - 1.412 0.081 0.05 0.062 0.24 0.96 1.24 
All detailed areas are dusted - 2.147 0.0089 0.02 0.026 0.12 0.52 0.69 
Feed hoppers cleaned and disinfected - 1.684 0.061 0.03 0.041 0.19 0.85 1.13 
Wild birds have access to poultry houses 2.332 0.017 1.40 1.91 10.30 55.46 76.05 
n = 84; maximum re-scaled r2 = 56.3% *p-value is based on likelihood ratio test. 
